AspenBio Pharma, Inc. (APNB) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 128 transactions totaling $10.5M, demonstrating a bearish sentiment with -$1.3M in net insider flow. The most recent transaction on Aug 29, 2007 involved a sale of 500 shares valued at $3.0K.
No significant insider buying has been recorded for APNB in the recent period.
No significant insider selling has been recorded for APNB in the recent period.
Based on recent SEC filings, insider sentiment for APNB is bearish with an Insider Alignment Score of 44/100 and a net flow of -$1.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AspenBio Pharma, Inc. (APNB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading APNB stock, having executed 128 transactions in the past 90 days. The most active insider is Opportunity Partners, L.p. Talon (Executive), who has made 1 transactions totaling $3.3M.
Get notified when executives and directors at APNB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 29, 2007 | I. Hepler Douglas | Executive | Sale | 500 | $5.95 | $3.0K | |
| Aug 29, 2007 | I. Hepler Douglas | Executive | Sale | 500 | $5.80 | $2.9K | |
| Aug 29, 2007 | I. Hepler Douglas | Executive | Sale | 4,000 | $6.00 | $24.0K | |
| Aug 16, 2007 | G. Donnelly Richard | Executive | Purchase | 2,000 | $4.60 | $9.2K | |
| Jul 18, 2007 | Ltd. 1837 Partners | Executive | Sale | 25,140 | $5.43 | $136.5K | |
| Jul 18, 2007 | Ltd. 1837 Partners | Executive | Sale | 6,330 | $5.43 | $34.4K | |
| Jul 18, 2007 | Ltd. 1837 Partners | Executive | Sale | 6,030 | $5.43 | $32.7K | |
| Jul 17, 2007 | Qp L.p. 1837 Partners | Executive | Sale | 570 | $5.33 | $3.0K | |
| Jul 17, 2007 | Qp L.p. 1837 Partners | Executive | Sale | 600 | $5.33 | $3.2K | |
| Jul 17, 2007 | Qp L.p. 1837 Partners | Executive | Sale | 2,382 | $5.33 | $12.7K | |
| Jul 16, 2007 | Qp L.p. 1837 Partners | Executive | Sale | 1,680 | $5.33 | $9.0K | |
| Jul 16, 2007 | Qp L.p. 1837 Partners | Executive | Sale | 400 | $5.33 | $2.1K | |
| Jul 16, 2007 | Qp L.p. 1837 Partners | Executive | Sale | 420 | $5.33 | $2.2K | |
| Jul 11, 2007 | L.p. 1837 Partners | Executive | Sale | 6,992 | $4.67 | $32.7K | |
| Jul 11, 2007 | L.p. 1837 Partners | Executive | Sale | 7,208 | $4.66 | $33.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 43 | $5.9M | 37.1% |
Exercise (Options)(X) | 19 | $5.3M | 33.4% |
Purchase(P) | 63 | $4.6M | 29.0% |
Award(A) | 3 | $78.8K | 0.5% |
Insider activity at AspenBio Pharma, Inc. shows mixed signals across all time. While $4.6M in purchases indicates some executive confidence,$5.9M in sales balances the picture, resulting in a modest net flow of -$1.3M.14 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Opportunity Partners, L.p. Talon, has transacted $3.3M during this period.